GreenLight Biosciences CEO and leadership

Dr. Andrey J. Zarur is a Chief Executive Officer at Greenlight Biosciences Inc and is based in United States.

Prof. Swartz, a leading expert in the field of cell-free protein synthesis, is a director and founder of Sutro Biopharma. He holds the James H. Clark Professorship in the School of Engineering at Stanford University and is a professor in the departments of bioengineering and chemical engineering. Prof. Swartz is a member of the National Academy of Engineering with over twenty years of industrial experience at Eli Lilly and Genentech prior to joining Stanford in 1998. He received his undergraduate degree in chemical engineering from the South Dakota School of Mines and his graduate degree from the Massachusetts Institute of Technology. Prof. Swartz is an author and a co-author on numerous scientific publications dealing with protein expression and advancement of cell-free protein production technology. ''I am delighted to expand my involvement with Sutro through the appointment as scientific advisor,'' said Prof. Swartz. ''Sutro has made tremendous progress within the past year, and the scientific advisory board will be tasked with helping to guide Sutro's management as they work to expand the company's proprietary pipeline as well as the projects with current and new partners.''

Amin leads efforts to use GreenLight’s platform to develop and launch vaccines and Amin Khan joined GreenLight from GSK’s Vaccines business, where he was a member of the R&D leadership team. As head of GSK’s Technical R&D organization, he led Vaccines R&D Acceleration, where he was responsible for end-to-end accelerated development of the vaccine portfolio. With 25 years of pharmaceutical and vaccines R&D experience, Khan’s recent work enabled the development and launch of Bexsero® & Shingrix® vaccines for meningitis B and shingles, respectively. He has also contributed to the development of mid-cycle vaccines at GSK (Vaccines for RSV, HSV, and CMV) and held accountability for scientific gating and prioritization of GSK’s vaccine discovery portfolio. Khan is co-inventor for at least 16 patents and recently co-edited “Quality by Design—An Indispensable Approach to Accelerate Biopharmaceutical Product Development.” Amin holds a Ph.D. in pharmaceutical sciences from the University of Nottingham.

Carole Cobb is the Senior Vice President, Operations & Engineering at Cobalt Technologies Inc. Ms. Cobb has over 25 years experience in Biotechnology/Fermentation-based Commercial Manufacturing, Process Development, Plant Operations and Supply Chain Management. Ms. Cobb was formerly the SVP, Global Supply, for Danisco A/S and Genencor International. During her tenure at Danisco/Genencor, Ms. Cobb successfully led the companies' biotechnology-based manufacturing strategy, growth and implementation, more than doubling the manufacturing infrastructure, including new plant construction and major capital expansions in Asia, South America and Europe, while increasing the output by more than 4X. Ms. Cobb oversaw ten manufacturing plants and 3 major warehouses worldwide. Ms. Cobb holds a M.B.A. in Finance. B.S. in Chemical Engineering, Biochemistry and Cell and Molecular Biology.

Charu leads all aspects of GreenLight’s Human Resources function with the goal of delivering innovative and efficient people programs that are aligned with the company’s mission and values. She has deep global experience across multiple industries of delivering business objectives through effective talent strategies. Most recently, she served as Group Vice President of Talent Strategies for Bright Horizons Family Solutions where she played a critical role in defining the human capital agenda to support the company strategy. Prior to Bright Horizons, she was VP of Human Resources at iRobot where she is credited for partnering with the leaders to deliver cultural transformation and global growth that resulted in doubling the size of the company. Charu has also led talent and HR functions at Keurig Green Mountain, Dana Holding Corporation, Delphi Automotive Systems and General Motors.

Susan Keefe is a successful executive with experience in Finance, Human Resources, Administration, Corporate Development, Compliance and Marketing. Trusted adviser to the leadership team and Board of Directors guiding all areas of HR and Finance and helping focus team on effective decision making and powerful communications to enable better business outcomes.Background includes Life Sciences startups to middle market companies along with Proctor & Gamble and PwC. Experience complemented with an MBA from the University of Chicago. Competencies include: ● Financial and HR Leadership● Strategic Planning● Operational Effectiveness● Mergers and Acquisitions Leadership● Organizational Change Management● Risk Management

Dr. Andrey J. Zarur is a Chief Executive Officer at Greenlight Biosciences Inc and is based in United States.

Prof. Swartz, a leading expert in the field of cell-free protein synthesis, is a director and founder of Sutro Biopharma. He holds the James H. Clark Professorship in the School of Engineering at Stanford University and is a professor in the departments of bioengineering and chemical engineering. Prof. Swartz is a member of the National Academy of Engineering with over twenty years of industrial experience at Eli Lilly and Genentech prior to joining Stanford in 1998. He received his undergraduate degree in chemical engineering from the South Dakota School of Mines and his graduate degree from the Massachusetts Institute of Technology. Prof. Swartz is an author and a co-author on numerous scientific publications dealing with protein expression and advancement of cell-free protein production technology. ''I am delighted to expand my involvement with Sutro through the appointment as scientific advisor,'' said Prof. Swartz. ''Sutro has made tremendous progress within the past year, and the scientific advisory board will be tasked with helping to guide Sutro's management as they work to expand the company's proprietary pipeline as well as the projects with current and new partners.''

Dr. Andrey J. Zarur is a Chief Executive Officer at Greenlight Biosciences Inc and is based in United States.